Fibrin disc treatment targets the root cause of discogenic pain by sealing annular tears with FDA-approved fibrin sealant. Discogenic pain originates in the disc itself; sealing the tear addresses the source rather than the downstream symptom. The mechanism is reparative, supporting biologic healing of the annulus over weeks to months.
Key Takeaways
- Discogenic pain originates in the disc itself.
- Annular tears are the most common driver.
- The fibrin procedure addresses the tear directly.
- Mechanism is reparative — fibrin scaffolds tissue healing.
- Root-cause treatment correlates with durable outcomes.
What This Guide Covers
- What does ‘discogenic’ mean?
- Why is the tear the root cause?
- How does fibrin target the root?
- Why does root-cause treatment correlate with durability?
What does ‘discogenic’ mean?
Discogenic pain is pain originating in a spinal disc. The most common source is an annular tear, which both stimulates the densely innervated outer annulus and leaks inflammatory chemistry onto surrounding tissue.
Why is the tear the root cause?
The tear is the structural lesion that generates the pain signal. Without sealing the tear, the pain generator remains active. Symptom-management approaches produce intermittent relief while the lesion persists.
How does fibrin target the root?
The procedure delivers FDA-approved fibrin sealant directly into the tear under fluoroscopic guidance. The fibrin scaffolds tissue healing, creating conditions for the annulus to close. The mechanism is reparative.
Why does root-cause treatment correlate with durability?
Durable outcomes follow durable repair. Symptom-management approaches mask while the lesion persists; reparative approaches change the structure that was generating pain. The 83% long-term success rate in published cohorts reflects this.
Clinical Note
Patients hear ‘root cause’ frequently in marketing materials. Our clinical staff defines it specifically: the structural lesion that, when addressed, removes the pain generator. For discogenic pain, that lesion is most often an annular tear. The procedure addresses it directly. The Valor team is careful not to overpromise — root-cause treatment is not magic, but for patients whose imaging shows the right pattern, the procedure does what its mechanism suggests.
Frequently Asked Questions
Is ‘root cause’ a marketing claim or clinical claim?
For annular tears, it is a clinical claim grounded in disc anatomy and innervation.
How long until I know it worked?
Most patients have a sense by 8 to 12 weeks; full benefit emerges over 3 to 6 months.
Can the procedure address multiple roots at once?
Yes, when imaging shows multiple addressable lesions.
Related reading:
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
